ARTICLE INFO

Article Type

Original Research

Authors

Roshani Pour   N. (1)
Jabbarpour Bonyadi   M. (*)
Jabbarpour Bonyadi   M.H. (2)






(*) Center of Excellence for Biodiversity , Natural Sciences Faculty, University of Tabriz, Tabriz, Iran
(1) Biology Department, Genetic School, Tabriz Branch, Islamic Azad University, Tabriz, Iran
(2) Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Correspondence

Address: Natural Sciences Faculty, University of Tabriz, 29 Bahman Street, Tabriz, Iran
Phone: +98 (41) 33357622
Fax: +98(41) 33357622
jabbarpour@tabrizu.ac.ir

Article History

Received:  December  15, 2016
Accepted:  February 27, 2016
ePublished:  July 22, 2017

BRIEF TEXT


Age-related Macular Degeneration (AMD) is one of the main causes of blindness of millions of people over the age of 60 years old [1].

Visual disturbance in AMD is accompanied by degeneration of retinal pigment epithelial cells (RPE) and light receptor cells sensitive to light. The damage of these cells causes chronic inflammation in the eye and ultimately an abnormal form of drusen that disrupts the function of PRE cell [2]. ... [3-13]. The exact role of CFB in the development of AMD has not yet been proven. Despite this, it has been shown that this protective CFB protein, which contains glutamine at position 32, has a hemolytic decreased activity compared to a protein containing arginine [14, 15]. … [16-17].

The aim of this study was to investigate the association of polymorphism of CF3 gene rs4151667 with AMD (dry type with geographic atrophy phenotype) in northeastern population of Iran.

This study is descriptive, and cross-sectional.

This study was conducted in 2016-2017 in people over 60 years of age with dry type AMD with geographical atrophy phenotype in Gonabad City.

44 persons over 60 years of age were randomly selected.44 persons over 60 years of age were randomly selected.

From both patient and control groups, after completing the blood donation consent form, the blood was taken. Genomic DNA was extracted from 4 ml human blood using the standard DNA extraction protocol (saturated salt) [18]. Extracted DNA was amplified by Polymerase Chain Reaction (PCR) and the genotype of persons was determined using PCR-RFLP (Polymerase Chain Reaction based on Restriction Fragment Length Polymorphism) at the position of c.26T>A (Figure 1). To ensure the accuracy of the identified genotypes, a number of samples were sequenced that confirmed the results of PCR-RFLP. Statistical analysis: Frequency of each genotype in two groups was analyzed using 2x2 Contingency software and Chi-square test.

Of the 44 patients, 42 (95.5%) had TT genotype and 2 (4.5%) had AT genotype, and from 50 persons in the control group, 44(88.0%) and 6 (12.0%) had AT genotype respectively. In none of the groups, there was AA genotype. The two groups were significantly different in terms of frequency of TT and AT genotypes (p<0.05). The percentage of chance for the TT genotype was about 2.8 and the frequency of the T Allele was high in the patient group compared to the control group (Table 1).

… [19-30]. In a study conducted in 2012 among southern population of Iran and Fars province, the association between G6721T polymorphism in the XRCC7 gene and AMD was studied. In this research, the subjects were classified according to the type of occupation (open environment and close environment). The results showed that the T allele of the G6721T polymorphism of the XRCC7 gene was associated with an increased risk of AMD in those exposed to sunlight [31]. … [32-33]. In a study conducted among an Indian group, there was no association between polymorphism rs4151667 of CFB gene and AMD. Therefore, the genetic effect of CFB polymorphism on exudative AMD in population that are white is important. However it is not important in Korean population [34, 35]. In different studies in Asian population (Japan, China, and Korea), no significant association was found between polymorphism rs4151667 (c.26T> A) and AMD, and the frequency of the dangerous allele for s4151667 in CFB was very low [36].... [37].

It is better to check the association of this gene with AMD in RNA level using more molecular testing. Also, it is recommended to study the subjects in terms of the variables of smoking and exposure to light that are important factors involved in the development of AMD.

The limitation of this study was small number of patients.

Rs4151667 polymorphism CFB gene plays a significant role in the progression of AMD (dry type with geographic atrophy phenotype) in the northeastern population of Iran. The presence of TT genotype in individuals increases the probability of AMD diseases by 2.8 times that of non-TT genotypes, and AT genotype plays a protective role against this disease.

The authors of this article are very thankful to all persons in patient and control groups to collaborate on this research project.

Non-declared

Ethical confirmation of this research was obtained from the Ethics Committee of Gonabad University of Medical Sciences with the code GMU.REC.1393.73.

The funding source of this project is from the biodiversity science hub.

TABLES and CHARTS

Show attach file


CITIATION LINKS

[1]David L, Lincoln V, Johnson, Dennis O. Clegg cellular models and therapies for age-related macular degeneration. Dis Model Mech. 2015;8(5):421-7.
[2]Berman K, Brodaty H. Psychosocial effects of age-related macular degeneration. Int Psychogeriatr. 2006;18(3):415-28.
[3]Thakkinstian A, McKay GJ, McEvoy M, Chakravarthy U, Chakrabarti S, Silvestri G, et al. Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: A HuGE review and meta-analysis. Am J Epidemiol. 2011;173(12):1365-79.
[4]Munoz B, West SK, Rubin GS, Schein OD, Quigley HA, et al. Causes of blindness and visual impairment in a population of older Americans: The salisbury eye evaluation study. Arch Ophthalmol. 2000;118(6):819-25.
[5]Hirvela H, Luukinen H, Laara E, Sc L, Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology. 1996;103(6):871-7.
[6]Weiter JJ, Delori FC, Wing GL, Fitch KA. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci. 1986;27(2):145-52.
[7]Kawasaki R, Wang JJ, Ji GJ, Taylor B, Oizumi T, Daimon M, et al. Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: The Funagata study. Ophthalmology. 2008;115(5):1376-81.
[8]Walport MJ. Complement first of two parts. N Engl J Med. 2001;344(14):1058-66.
[9]Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;99(23):14682-7.
[10]¬Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308(5270):384-9.
[11]¬Francis PJ, Hamon SC, Ott J, Weleber RG, Klein ML. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J Med Genet. 2009;46(5):300-7.
[12]Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med. 2006;38(8):592-604.
[13]Markiewski MM, Deangelis RA, Lambris JD. Complexity of complement activation in sepsis. J Cell Mol Med. 2008;12(6A):2245-54.
[14]¬Lokki ML, Koskimies SA. Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes. Immunogenetics. 1991;34(4):242-6.
[15]Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, et al. Risk factors for incident age-related macular degeneration: Pooled findings from 3 continents. Ophthalmology. 2004;111(7):1280-7.
[16]Xing C, Sivakumaran TA, Wang JJ, Rochtchina E, Joshi T, Smith W, et al. Complement factor H polymorphisms, renal phenotypes and age-related macular degeneration: The Blue Mountains Eye Study. Genes Immun. 2008;9(3):231-9.
[17]Kew¬ RR, Ghebrehiwet B, Janoff A. Characterization of the third component of complement (C3) after activation by cigarette smoke. Clin Immunol Immunopathol. 1987;44(2):248-58.
[18]Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
[19]Klein ML, Schultz DW, Edwards A, Matise TC, Rust K, Berselli CB, et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol. 1998;116(8):1082-8.
[20]Wong WL, Xinyi Su, Xiang Li, Cheung CM, Klein R, Cheng C, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106-16.
[21]Bressler SB, Munoz B, Solomon SD, West SK. Racial differences in the prevalence of age-related macular degeneration: The Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol. 2008;126(2):241-5.
[22]Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: A meta-analysis. Ophthalmology. 2012;119(3):571-80.
[23]Klein R, Klein BE, Knudtson MD, Wong TY, Cotch MF, Liu K, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology. 2006;113(3):373-80.
[24]¬Fotouhi A, Hashemi H, Mohammad K, Jalali KH. The prevalence and causes of visual impairment in Tehran: the Tehran Eye Study. Br J Ophthalmol. 2004;88(6):740-5.
[25]Swaroop A, Chew EY, Rickman CB, Abecasis GR. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet. 2009;10:19-43.
[26]Ratnapriya R, Chew EY. Age-related macular degeneration-clinical review and genetic update. Clin Genet. 2013;84(2):160-6.
[27]Scholl HP, Charbel Issa P, Walier M, Janzer S, Pollok-Kopp B, Börncke F, et al. Systemic complement activation in age-related macular degeneration. PLoS One. 2008;3(7):e2593.
[28]Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci. 2009;50(12):5818-27.
[29]Baird PN, Islam FM, Richardson AJ, Cain M, Hunt N, Guymer R. Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration. Invest Ophthalmol Vis Sci. 47(10):4194-8.
[30]Baird PN, Guida E, Chu DT, Vu HT, Guymer RH. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45(5):1311-5.
[31]Saadat I, Vakili-Ghartavol R, Farvardin-Jahromi M, Saadat M. Association betweenExudative Age-related Macular Degeneration and the G6721T Polymorphism of XRCC7 inOutdoor Subjects. Korean J Ophthalmol. 2012;26(6):423-7.
[32]Liu X, Zhao P, Tang S, Lu F, Hu J, Lei C, et al. Association study of complement factor H, C2, CFB, and C3 and age related macular degeneration in a Han Chinese population. Retina. 2010;30(8):1177-84.
[33]Lee KY, Vithana EN, Mathur R, Yong VH, Yeo IY, Thalamuthu A, et al. Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2008;49(6):2613-9.
[34]Cui L, Zhou H, Yu J, Sun E, Zhang Y, Jia W, et al. Noncoding variant in the complement factor H gene and risk of exudative age-related macular degeneration in a Chinese population. Invest Ophthalmol Vis Sci. 2010;51(2):1116-20.
[35]Kaur I, Katta S, Reddy RK, Narayanan R, Mathai A, Majji AB, et al. The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51(1):59-63.
[36]Thakkinstian A, McEvoy M, Chakravarthy U, Chakrabarti S, McKay GJ, Ryu E, et al. The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis. Am J Epidemiol. 2012;176(5):361-72.
[37]Contreras AV, Zenteno JC, Fernández-López JC, Rodríguez-Corona U, Falfán-Valencia R, Sebastian L, et al. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans. Mol Vis. 2014;20:105-16.